piwik-script

Intern
Lehrstuhl für klinische Epidemiologie und Biometrie

Prof. Dr. Sylke Zeißig

Prof. Dr. Sylke Zeißig

Professorin für Klinische Epidemiologie von Krebserkrankungen
Petrinistr. 33a

Brückenprofessur mit dem Bayerischen Landesamt für Gesundheit und Lebensmittelsicherheit (LGL) und Leitung des Regionalzentrums Würzburg des Bayerischen Krebsregisters

kurzer Lebenslauf

seit 2021

Professur für Klinische Epidemiologie von Krebserkrankungen am Institut für Klinische Epidemiologie und Biometrie, Universität Würzburg
2020 Habilitation für „Epidemiologie“, Johannes Gutenberg–Universität Mainz
2007–2011 Masterstudiengang Epidemiologie, Universitätsmedizin der Johannes Gutenberg - Universität Mainz
2015 - 2021

Ärztliche Leiterin der Krebsregister Rheinland-Pfalz gGmbH, Mainz

2009-2015 Leiterin der Vertrauensstelle des Krebsregisters Rheinland-Pfalz, Mainz
2005 – 2009 Wissenschaftliche Mitarbeiterin am Institut für Medizinische Biometrie, Epidemiologie und Informatik (IMBEI), Universitätsmedizin der Johannes Gutenberg - Universität Mainz
1997 Approbation und Promotion, Johannes Gutenberg–Universität Mainz
1988-1995 Studium der Humanmedizin, Johannes Gutenberg–Universität Mainz

 

wissenschaftliche Schwerpunkte

Krebsregistrierung, Forschung mit Krebsregisterdaten, Langzeitüberlebende nach Krebs, Epidemiologie seltener Tumoren (speziell Sarkome)

Hauptpublikationen der letzten Jahre 

Scholz-Kreisel P, Becker C, Kaiser M, Mahmoudpour SH, Voigt M, Ressing M, Blettner M, Calaminus G, Baust K, Scholtes C, Zimmerman M, Zeissig SR, Schmidberger H, Karle H, Meyer-Oldenburg S, Kaatsch P, Spix C.
Subsequent primary neoplasms after childhood cancer therapy – design and description of the German nested case–control study
STATT-SCAR. Cancer Causes Control (2023). https://doi.org/10.1007/s10552-023-01760-5

Zeissig SR, Emrich K, Reinwald F, Kasper B, Kleihues-van Tole K, Justenhoven C, Wardelmann E, Hohenberger P.
Sarcoma research with cancer registry data - Data and peculiarities of Germany in the light of other countries.

Oncol Res Treat. 2023 Jun 28. doi: 10.1159/000531724. Epub ahead of print. PMID: 37379812.

Thong MSY, Doege D, Weißer L, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B, Nennecke A, Waldmann A, Zeissig SR, Brenner H, Arndt V.
Persisting Deficits in Health-Related Quality of Life of Colorectal Cancer Survivors 14-24 Years Post-Diagnosis: A Population-Based Study.

Curr Oncol. 2023 Mar 14;30(3):3373-3390. doi: 10.3390/curroncol30030257. PMID: 36975470; PMCID: PMC10047200.

Abdalla TSA, Pieper L, Kist M, Thomaschewski M, Klinkhammer-Schalke M, Zeissig SR, Tol KK, Wellner UF, Keck T, Hummel R.
Gastrointestinal stromal tumors of the upper GI tract: population-based analysis of epidemiology, treatment and outcome based on data from the German Clinical Cancer Registry Group.
J Cancer Res Clin Oncol. 2023 Mar 23. doi: 10.1007/s00432-023-04690-6. Epub ahead of print. PMID: 36959341.

Kist M, Thomaschewski M, Keck Y, Abdalla TSA, Zeissig SR, Kleihues-van Tol K, Wellner UF, Keck T, Hoeppner J, Hummel R.
Specifics of Young Gastric Cancer Patients: A Population-Based Analysis of 46,110 Patients with Gastric Cancer from the German Clinical Cancer Registry Group.
Cancers (Basel). 2022 Nov 30;14(23):5927. doi: 10.3390/cancers14235927. PMID: 36497406; PMCID: PMC9739447.

Klinkhammer-Schalke M, Wesselmann S, Bruns J, Nettekoven G, Tillack A, Follmann M, Arndt V, Graeven U, Hartz T, Illmer T, Inwald EC, Kaiser T, Nothacker M, Ortmann O, Schmidt S, Schmitt J, Zeissig SR, Seufferlein T.
Weiterentwicklung und Vernetzung der onkologischen Versorgungsstrukturen, der Qualitätssicherung und der Forschung [Further Development and Interoperability in Oncological Care Structures, Quality Control and Research].
​​​​​​​ Gesundheitswesen. 2023 Jul;85(7):649-656. German. doi: 10.1055/a-1926-6818. Epub 2022 Nov 3. PMID: 36328158; PMCID: PMC10338075.

Abdalla TSA, Klinkhammer-Schalke M, Zeissig SR, Tol KK, Honselmann KC, Braun R, Bolm L, Lapshyn H, Litkevych S, Zemskov S, Begum N, Kulemann B, Hummel R, Wellner UF, Keck T, Deichmann S.
Prognostic factors after resection of locally advanced non-functional pancreatic neuroendocrine neoplasm: an analysis from the German Cancer Registry Group of the Society of German Tumor Centers.
J Cancer Res Clin Oncol. 2023 Apr 24. doi: 10.1007/s00432-023-04785-0. Epub ahead of print. PMID: 37095413.

Radespiel-Tröger M, Müller-Nordhorn J, Zeissig SR
Epidemiologie gastrointestinaler Stromatumoren in Bayern 2003–2019: Zunahme der Inzidenz und verbessertes Überleben. 
Die Onkologie. 2023;29:89–94.doi:10.1007/s00761-022-01277-7

Klinkhammer-Schalke M, Wesselmann S, Bruns J, Nettekoven G, Tillack A, Follmann M, Arndt V, Graeven U, Hartz T, Illmer T, Inwald EC, Kaiser T, Nothacker M, Ortmann O, Schmidt S, Schmitt J, Zeissig SR, Seufferlein T. 
Weiterentwicklung und Vernetzung der onkologischen Versorgungsstrukturen, der Qualitätssicherung und der Forschung [Further Development and Interoperability in Oncological Care Structures, Quality Control and Research]. 
Gesundheitswesen. 2022 Nov 3. German. doi: 10.1055/a-1926-6818. Epub ahead of print. PMID: 36328158.

Kist M, Thomaschewski M, Keck Y, Abdalla TSA, Zeissig SR, Kleihues-van Tol K, Wellner UF, Keck T, Hoeppner J, Hummel R. 
Specifics of Young Gastric Cancer Patients: A Population-Based Analysis of 46,110 Patients with Gastric Cancer from the German Clinical Cancer Registry Group. 
Cancers (Basel).2022 Nov 30;14(23):5927. doi: 10.3390/cancers14235927. PMID: 36497406; PMCID: PMC9739447.

Pokora RM, Büttner M, Schulz A, Schuster AK, Merzenich H, Teifke A, Michal M, Lackner K, Münzel T, Zeissig SR, Wild PS, Singer S, Wollschläger D
Determinants of mammography screening participation-a cross-sectional analysis of the German population-based Gutenberg Health Study (GHS)
PLoS One. 2022 Oct 5;17(10):e0275525. doi: 10.1371/journal.pone.0275525

Liang LA, Zeissig SR, Schauberger G, Merzweiler S, Radde K, Fischbeck S, Ikenberg H, Blettner M, Klug SJ
Colposcopy non-attendance following an abnormal cervical cancer screening result: a prospective population-based cohort study
BMC Womens Health. 2022 Jul 9;22(1):285. doi: 10.1186/s12905-022-01851-6

Bolm L, Zemskov S, Zeller M, Baba T, Roldan J, Harrison JM, Petruch N, Sato H, Petrova E, Lapshyn H, Braun R, Honselmann KC, Hummel R, Dronov O, Kirichenko AV, Klinkhammer-Schalke M, Kleihues-van Tol K, Zeissig SR, Rades D, Keck T, Fernandez-Del Castillo C, Wellner UF, Wegner RE
Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Cancer Database (NCDB) and the German Cancer Registry Group of the Society of German Tumor Centers (GCRG/ADT)
Cancers (Basel). 2022 Feb 9;14(4):868. doi: 10.3390/cancers14040868

Braun R, Klinkhammer-Schalke M, Zeissig SR, Kleihus van Tol K, Bolm L, Honselmann KC, Petrova E, Lapshyn H, Deichmann S, Abdalla TSA, Heckelmann B, Bronsert P, Zemskov S, Hummel R, Keck T, Wellner UF
Clinical Outcome and Prognostic Factors of Pancreatic Adenosquamous Carcinoma Compared to Ductal Adenocarcinoma-Results from the German Cancer Registry Group 
Cancers (Basel). 2022 Aug 16;14(16):3946. doi: 10.3390/cancers14163946

Doege D, Thong MSY, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Nennecke A, Pritzkuleit R, Waldmann A, Zeissig SR, Brenner H, Arndt V
Clinical and sociodemographic determinants of disease-specific health-related quality of life in long-term breast cancer survivors
J Cancer Res Clin Oncol. 2022 Dec;148(12):3461-3473. doi: 10.1007/s00432-022-04204-w

Deichmann S, Dworschak O, Kulemann B, Höppner J, Bolm L, Klinkhammer-Schalke M, Zeissig SR, Kleihus van Tol K, Braun R, Lapshyn H, Keck T, Wellner UF, Honselmann KC
Inzidenz, Behandlung und Überleben beim Pankreaskarzinom – Daten der bundesweiten onkologischen Qualitätskonferenz aus chirurgischer Perspektive [Incidence, Treatment and Survival in Pancreatic Cancer- Data of the Nationwide Oncological Quality Conference from a Surgical Perspective]
Zentralbl Chir. 2022 Apr;147(2):147-154. German. doi: 10.1055/a-1768-1012

Petrova E, Wellner J, Nording AK, Braun R, Honselmann KC, Bolm L, Hummel R, Klinkhammer-Schalke M, Zeissig SR, Kleihues van Tol K, Timme-Bronsert S, Bronsert P, Zemskov S, Keck T, Wellner UF
Survival Outcome and Prognostic Factors for Pancreatic Acinar Cell Carcinoma: Retrospective Analysis from the German Cancer Registry Group
Cancers (Basel). 2021 Dec 4;13(23):6121. doi: 10.3390/cancers13236121

Thong MSY, Doege D, Weißer L, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Nennecke A, Waldmann A, Zeissig SR, Pritzkuleit R, Schlander M, Brenner H, Arndt V
Health and life insurance-related problems in very long-term cancer survivors in Germany: a population-based study
J Cancer Res Clin Oncol. 2022 Jan;148(1):155-162. doi: 10.1007/s00432-021-03825-x

Petrova E, Wellner J, Nording AK, Braun R, Honselmann KC, Bolm L, Hummel R, Klinkhammer-Schalke M, Zeissig SR, Kleihues van Tol K, Timme-Bronsert S, Bronsert P, Zemskov S, Keck T, Wellner UF.
Survival Outcome and Prognostic Factors for Pancreatic Acinar Cell Carcinoma: Retrospective Analysis from the German Cancer Registry Group.
Cancers (Basel). 2021 Dec 4;13(23):6121. doi: 10.3390/cancers13236121.
PMID: 34885230

Thong MSY, Doege D, Weißer L, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Nennecke A, Waldmann A, Zeissig SR, Pritzkuleit R, Schlander M, Brenner H, Arndt V.
Health and life insurance-related problems in very long-term cancer survivors in Germany: a population-based study.
J Cancer Res Clin Oncol. 2021 Oct 13. doi: 10.1007/s00432-021-03825-x. Online ahead of print.
PMID: 34642793

Liu Z, Doege D, Thong MSY, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Nennecke A, Waldmann A, Zeißig SR, Pritzkuleit R, Arndt V.
Distress mediates the relationship between cognitive appraisal of medical care and benefit finding/posttraumatic growth in long-term cancer survivors.
Cancer. 2021 Oct ;127(19):3680-3690. Epub 2021 Jul.

Liu Z, Thong MSY, Doege D, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Waldmann A, Zeissig SR, Pritzkuleit R, Brenner H, Arndt V.
Prevalence of benefit finding and posttraumatic growth in long-term cancer survivors: results from a multi-regional population-based survey in Germany.
Br J Cancer. 2021 Sep;125(6):877-883. doi: 10.1038/s41416-021-01473-z. Epub 2021 Jul 2.
PMID: 34215852 Free PMC article.

Doege D, Thong MSY, Weißer L, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B, Nennecke A, Pritzkuleit R, Waldmann A, Zeissig SR, Brenner H, Arndt V.
Health-Related Quality of Life in Very Long-Term Cancer Survivors 14-24 Years Post-Diagnosis Compared to Population Controls: A Population-Based Study.
Cancers (Basel). 2021 Jun 1;13(11):2754. doi: 10.3390/cancers13112754.
PMID: 34206134

Liang LA, Einzmann T, Franzen A, Schwarzer K, Schauberger G, Schriefer D, Radde K, Zeissig SR, Ikenberg H, Meijer CJLM, Kirkpatrick CJ, Kölbl H, Blettner M, Klug SJ.
Cervical Cancer Screening: Comparison of Conventional Pap Smear Test, Liquid-Based Cytology, and Human Papillomavirus Testing as Stand-alone or Cotesting Strategies.
Cancer Epidemiol Biomarkers Prev. 2021 Mar;30(3):474-484. doi: 10.1158/1055-9965.EPI-20-1003. Epub 2020 Nov 13.
PMID: 33187968

Doege D, Thong MSY, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B, Pritzkuleit R, Waldmann A, Zeissig SR, Brenner H, Arndt V.
Age-specific prevalence and determinants of depression in long-term breast cancer survivors compared to female population controls.
Cancer Med. 2020 Nov;9(22):8713-8721. doi: 10.1002/cam4.3476. Epub 2020 Oct 6.

González Maldonado S, Motsch E, Trotter A, Kauczor HU, Heussel CP, Hermann S, Zeissig SR, Delorme S, Kaaks R.
Overdiagnosis in lung cancer screening: Estimates from the German Lung Cancer Screening Intervention Trial.
Int J Cancer. 2021 Mar 1;148(5):1097-1105. doi: 10.1002/ijc.33295. Epub 2020 Sep 23.
PMID: 32930386

Adam S, Doege D, Koch-Gallenkamp L, Thong MSY, Bertram H, Eberle A, Holleczek B, Pritzkuleit R, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Jansen L, Rohrmann S, Brenner H, Arndt V.
Age-specific health-related quality of life in disease-free long-term prostate cancer survivors versus male population controls-results from a population-based study.
Support Care Cancer. 2020 Jun;28(6):2875-2885. doi: 10.1007/s00520-019-05120-5. Epub 2019 Nov 18.
PMID: 31736000

Arndt V, Holleczek B, Kajüter H, Luttmann S, Nennecke A, Zeissig SR, Kraywinkel K, Katalinic A.
Data from Population-based Cancer Registration for Secondary Data Analysis: Methodological Challenges and Perspectives.
Gesundheitswesen. 2020 Mar;82(S 01):S62-S71. doi: 10.1055/a-1009-6466. Epub 2019 Oct 29.
PMID: 31663107

Thong MSY, Doege D, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Brenner H, Arndt V.
Age at Diagnosis and Sex Are Associated With Long-term Deficits in Disease-Specific Health-Related Quality of Life of Survivors of Colon and Rectal Cancer: A Population-Based Study.
Dis Colon Rectum. 2019 Nov;62(11):1294-1304. doi: 10.1097/DCR.0000000000001489.
PMID: 31567919

Thong MSY, Wolschon EM, Koch-Gallenkamp L, Waldmann A, Waldeyer-Sauerland M, Pritzkuleit R, Bertram H, Kajüter H, Eberle A, Holleczek B, Zeissig SR, Brenner H, Arndt V.
"Still a Cancer Patient"-Associations of Cancer Identity With Patient-Reported Outcomes and Health Care Use Among Cancer Survivors.
JNCI Cancer Spectr. 2018 Jul 5;2(2):pky031. doi: 10.1093/jncics/pky031. eCollection 2018 Apr.
PMID: 31360857

Adam S, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Pritzkuleit R, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Rohrmann S, Brenner H, Arndt V.
Health-related quality of life in long-term survivors with localised prostate cancer by therapy-Results from a population-based study.
Eur J Cancer Care (Engl). 2019 Sep;28(5):e13076. doi: 10.1111/ecc.13076. Epub 2019 May 2.
PMID: 31050091

Doege D, Thong MS, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Pritzkuleit R, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Jansen L, Brenner H, Arndt V.
Health-related quality of life in long-term disease-free breast cancer survivors versus female population controls in Germany.
Breast Cancer Res Treat. 2019 Jun;175(2):499-510. doi: 10.1007/s10549-019-05188-x. Epub 2019 Mar 2.
PMID: 30826935

Arndt V, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Pritzkuleit R, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Doege D, Thong MSY, Brenner H.
Return to work after cancer. A multi-regional population-based study from Germany.
Acta Oncol. 2019 May;58(5):811-818. doi: 10.1080/0284186X.2018.1557341. Epub 2019 Feb 19.
PMID: 30777496

Thong MSY, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Brenner H, Arndt V.
Age-specific health-related quality of life in long-term and very long-term colorectal cancer survivors versus population controls - a population-based study.
Acta Oncol. 2019 May;58(5):801-810. doi: 10.1080/0284186X.2018.1557340. Epub 2019 Feb 8.
PMID: 30736716

Tibubos AN, Ernst M, Brähler E, Fischbeck S, Hinz A, Blettner M, Zeissig SR, Weyer V, Imruck BH, Binder H, Beutel ME.
Fatigue in survivors of malignant melanoma and its determinants: a register-based cohort study.
Support Care Cancer. 2019 Aug;27(8):2809-2818. doi: 10.1007/s00520-018-4587-1. Epub 2018 Dec 11.
PMID: 30539313

Brunssen A, Jansen L, Eisemann N, Waldmann A, Weberpals J, Kraywinkel K, Eberle A, Holleczek B, Zeissig SR, Brenner H, Katalinic A; GEKID Cancer Survival Working Group.
A population-based registry study on relative survival from melanoma in Germany stratified by tumor thickness for each histologic subtype.
J Am Acad Dermatol. 2019 Apr;80(4):938-946. doi: 10.1016/j.jaad.2018.09.018. Epub 2018 Sep 20.
PMID: 30244061

Brunssen A, Jansen L, Eisemann N, Waldmann A, Weberpals J, Kraywinkel K, Eberle A, Holleczek B, Zeissig SR, Brenner H, Katalinic A; GEKID Cancer Survival Working Group.
Long-term relative survival from melanoma in Germany 1997-2013.
Melanoma Res. 2020 Aug;30(4):386-395. doi: 10.1097/CMR.0000000000000482.
PMID: 30020195

Doege D, Thong M, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Brenner H, Arndt V.
The role of psychosocial resources for long-term breast, colorectal, and prostate cancer survivors: prevalence and associations with health-related quality of life.
Support Care Cancer. 2019 Jan;27(1):275-286. doi: 10.1007/s00520-018-4317-8. Epub 2018 Jun 27.
PMID: 29951713

Fischbeck S, Weyer-Elberich V, Zeissig SR, Imruck BH, Blettner M, Binder H, Beutel ME.
Determinants of illness-specific social support and its relation to distress in long-term melanoma survivors.
BMC Public Health. 2018 Apr 17;18(1):511. doi: 10.1186/s12889-018-5401-1.
PMID: 29665805

Ressing M, Wardelmann E, Hohenberger P, Jakob J, Kasper B, Emrich K, Eberle A, Blettner M, Zeissig SR.
Strengthening health data on a rare and heterogeneous disease: sarcoma incidence and histological subtypes in Germany.
BMC Public Health. 2018 Feb 12;18(1):235. doi: 10.1186/s12889-018-5131-4.
PMID: 29433465

Zeissig SR, Weyer-Elberich V, Emrich K, Binder H, Fischbeck S, Imruck BH, Friedrich-Mai P, Beutel ME, Blettner M.
Recruiting former melanoma patients via hospitals in comparison to office-based dermatologists in a register-based cohort study that required indirect contact.
BMC Med Res Methodol. 2017 Nov 22;17(1):150. doi: 10.1186/s12874-017-0425-2.
PMID: 29166870

Singer S, Zeissig SR, Emrich K, Holleczek B, Kraywinkel K, Ressing M.
Incidence of lip malignancies in Germany-data from nine population-based cancer registries.
J Oral Pathol Med. 2017 Oct;46(9):780-785. doi: 10.1111/jop.12559. Epub 2017 Mar 2.
PMID: 28178758

Paschold M, Huber T, Maedge S, Zeissig SR, Lang H, Kneist W.
Laparoscopic assistance by operating room nurses: Results of a virtual-reality study.
Nurse Educ Today. 2017 Apr;51:68-72. doi: 10.1016/j.nedt.2017.01.008. Epub 2017 Jan 20.
PMID: 28131934

Arndt V, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, Zeissig SR, Brenner H.
Quality of life in long-term and very long-term cancer survivors versus population controls in Germany.
Acta Oncol. 2017 Feb;56(2):190-197. doi: 10.1080/0284186X.2016.1266089. Epub 2017 Jan 5.
PMID: 28055266

Hager B, Kraywinkel K, Keck B, Katalinic A, Meyer M, Zeissig SR, Scheufele R, Wirth MP, Huber J.
Increasing use of radical prostatectomy for locally advanced prostate cancer in the USA and Germany: a comparative population-based study.
Prostate Cancer Prostatic Dis. 2017 Mar;20(1):61-66. doi: 10.1038/pcan.2016.43. Epub 2016 Sep 13.
PMID: 27618951

Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, Zeissig SR, Brenner H, Arndt V.
Fear of recurrence in long-term cancer survivors-Do cancer type, sex, time since diagnosis, and social support matter?
Health Psychol. 2016 Dec;35(12):1329-1333. doi: 10.1037/hea0000374. Epub 2016 May 12.
PMID: 27175578

Eisemann N, Jansen L, Castro FA, Chen T, Eberle A, Nennecke A, Zeissig SR, Brenner H, Katalinic A; GEKID Cancer Survival Working Group.
Survival with nonmelanoma skin cancer in Germany.
Br J Dermatol. 2016 Apr;174(4):778-85. doi: 10.1111/bjd.14352. Epub 2016 Mar 22.
PMID: 26676514

Fischbeck S, Imruck BH, Blettner M, Weyer V, Binder H, Zeissig SR, Emrich K, Friedrich-Mai P, Beutel ME.
Psychosocial Care Needs of Melanoma Survivors: Are They Being Met?
PLoS One. 2015 Aug 21;10(8):e0132754. doi: 10.1371/journal.pone.0132754. eCollection 2015.
PMID: 26296089

Hager B, Kraywinkel K, Keck B, Katalinic A, Meyer M, Zeissig SR, Stabenow R, Froehner M, Huber J.
Integrated prostate cancer centers might cause an overutilization of radiotherapy for low-risk prostate cancer: A comparison of treatment trends in the United States and Germany from 2004 to 2011.
Radiother Oncol. 2015 Apr;115(1):90-5. doi: 10.1016/j.radonc.2015.02.024. Epub 2015 Mar 11.
PMID: 25770874

Beutel ME, Fischbeck S, Binder H, Blettner M, Brähler E, Emrich K, Friedrich-Mai P, Imruck BH, Weyer V, Zeissig SR.
Depression, anxiety and quality of life in long-term survivors of malignant melanoma: a register-based cohort study.
PLoS One. 2015 Jan 23;10(1):e0116440. doi: 10.1371/journal.pone.0116440. eCollection 2015.
PMID: 25615573

Zeissig SR, Singer S, Koch L, Zeeb H, Merbach M, Bertram H, Eberle A, Schmid-Höpfner S, Holleczek B, Waldmann A, Arndt V.
Utilisation of psychosocial and informational services in immigrant and non-immigrant German cancer survivors.
Psychooncology. 2015 Aug;24(8):919-25. doi: 10.1002/pon.3742. Epub 2014 Dec 19.
PMID: 25529132

Zeissig SR, Radde K, Kaiser M, Blettner M, Klug SJ.
[Quality assurance in an epidemiological cohort study: on-site monitoring in gynaecological practices].
Z Evid Fortbild Qual Gesundhwes. 2014;108(8-9):517-27. doi: 10.1016/j.zefq.2014.08.001. Epub 2014 Nov 5.
PMID: 25523851

Zeissig SR, Singer S, Koch L, Blettner M, Arndt V.
[Utilisation of Psycho-oncological Services in Hospitals and Outpatient Counselling Centres by Survivors of Breast, Colon and Prostate Cancer].
Psychother Psychosom Med Psychol. 2015 May;65(5):177-82. doi: 10.1055/s-0034-1395627. Epub 2014 Dec 8.
PMID: 25485601

Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A, Marcos-Gragera R, Stiller C, Azevedo e Silva G, Chen WQ, Ogunbiyi OJ, Rachet B, Soeberg MJ, You H, Matsuda T, Bielska-Lasota M, Storm H, Tucker TC, Coleman MP; CONCORD Working Group.
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).
Lancet. 2015 Mar 14;385(9972):977-1010. doi: 10.1016/S0140-6736(14)62038-9. Epub 2014 Nov 26.
PMID: 25467588

Bayer O, Krüger M, Koutsimpelas D, Emrich K, Ressing M, Zeissig SR, Simon C, Singer S.
[Changes in Incidence and Mortality Trends of Head and Neck Cancer in Rhineland-Palatinate, 2000-2009].
Laryngorhinootologie. 2015 Jul;94(7):451-8. doi: 10.1055/s-0034-1390455. Epub 2014 Nov 27.
PMID: 25429640

Bayer O, Cámara R, Zeissig SR, Ressing M, Dietz A, Locati LD, Ramroth H, Singer S.
Occupation and cancer of the larynx: a systematic review and meta-analysis.
Eur Arch Otorhinolaryngol. 2016 Jan;273(1):9-20. doi: 10.1007/s00405-014-3321-y. Epub 2014 Oct 14.
PMID: 25311307

Radespiel-Tröger M, Batzler WU, Holleczek B, Luttmann S, Pritzkuleit R, Stabenow R, Urbschat I, Zeissig SR, Meyer M; Im Namen der Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V.
[Rising incidence of papillary thyroid carcinoma in Germany].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Jan;57(1):84-92. doi: 10.1007/s00103-013-1884-1.
PMID: 24357177

Koch L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, Zeissig SR, Brenner H, Arndt V.
Fear of recurrence in long-term breast cancer survivors-still an issue. Results on prevalence, determinants, and the association with quality of life and depression from the cancer survivorship--a multi-regional population-based study.
Psychooncology. 2014 May;23(5):547-54. doi: 10.1002/pon.3452. Epub 2013 Nov 30.
PMID: 24293081

Kutschmann M, Fischer-Fröhlich CL, Schmidtmann I, Bungard S, Zeissig SR, Polster F, Kirste G, Frühauf NR.
The joint impact of donor and recipient parameters on the outcome of heart transplantation in Germany after graft allocation.
Transpl Int. 2014 Feb;27(2):152-61. doi: 10.1111/tri.12221. Epub 2013 Nov 29.
PMID: 24286113

Zeissig SR, Fischer-Froehlich CL, Polster F, Fruehauf NR, Kirste G, Schmidtmann I.
Current practice of heart donor evaluation in Germany: multivariable risk factor analysis confirms practicability of guidelines.
J Transplant. 2013;2013:701854. doi: 10.1155/2013/701854. Epub 2013 Sep 30.
PMID: 24198963

Paschold M, Huber T, Zeißig SR, Lang H, Kneist W.
Tailored instructor feedback leads to more effective virtual-reality laparoscopic training.
Surg Endosc. 2014 Mar;28(3):967-73. doi: 10.1007/s00464-013-3258-z. Epub 2013 Nov 2.
PMID: 24185749

Blettner M, Zeissig SR.
German mammography screening program: quality assurance.
Dtsch Arztebl Int. 2012 Nov;109(46):779-80. doi: 10.3238/arztebl.2012.0779. Epub 2012 Nov 16.
PMID: 23264825